NT_1170x120_1-11-18

D2 ­Consulting

Federal market ROI: Optimizing pharma investments

Federal market ROI: Optimizing pharma investments

The days of considering the federal segment a statutory liability with little value proposition to the overall commercial book of business are gone. The health systems managed by the Department of Veterans Affairs (VA) and Department of Defense (DoD) present tremendous direct revenue and indirect spillover opportunity. Federal payers are often cited as models for